Showing 221 - 240 results of 1,716 for search '"Tenofovir"', query time: 0.24s Refine Results
  1. 221

    Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settings. by Calvin Q Pan, Huy Trinh, Alan Yao, Ho Bae, Lillian Lou, Sing Chan, Study 123 Group

    Published 2014-01-01
    “…<h4>Background and aims</h4>Chronic hepatitis B (CHB) disproportionately affects the Asian-American population in the USA. Tenofovir disoproxil fumarate (TDF) has demonstrated potent antiviral activity in clinical trials, but data in Asian-Americans from community studies are lacking.…”
    Get full text
    Article
  2. 222
  3. 223
  4. 224

    Guides concerning tenofovir exposure via breastfeeding: A comparison of drug dosages by developmental stage by Xiaotong Hu, Liming Wang, Fujie Xu

    Published 2019-10-01
    “…Tenofovir disoproxil fumarate (TDF) is a prodrug of tenofovir, and after being administered orally, it converts to tenofovir in the blood. …”
    Get full text
    Article
  5. 225
  6. 226
  7. 227
  8. 228

    Uptake of tenofovir and emtricitabine into non-monocytic female genital tract cells with and without hormonal contraceptives by James AM, King JR, Ofotokun I, Sheth AN, Acosta EP

    Published 2013-08-01
    “…The goal of this study was to characterize intracellular uptake of tenofovir and emtricitabine using five surrogate cell lines of the female genital tract and determine whether exogenous hormones influence their uptake.Methods: Surrogate cell lines, ie, THP-1 (representing macrophages), BC-3 (CD8+), Ect1/E6E7 (squamous epithelial), HeLa (CD4+), and TF-1 (dendritic), were incubated for one hour with tenofovir and emtricitabine to assess uptake. …”
    Get full text
    Article
  9. 229
  10. 230
  11. 231

    Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence by Ruth Byrne, Ivana Carey, Kosh Agarwal

    Published 2018-07-01
    “…Tenofovir alafenamide (TAF), a novel prodrug of tenofovir was developed to deliver enhanced antiviral potency and reduced systemic toxicities by more efficient intracellular delivery of the active metabolite tenofovir disphosphate than tenofovir disoproxil fumarate (TDF). …”
    Get full text
    Article
  12. 232
  13. 233

    Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH) by Anna Gidari, Sara Benedetti, Sara Tordi, Anastasia Zoffoli, Debora Altobelli, Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Daniela Francisci

    Published 2023-12-01
    “…Background: Bictegravir (BIC), a recently introduced integrase inhibitor, is available in a single tablet regimen with tenofovir alafenamide (TAF) and emtricitabine (FTC) (BIC-STR). …”
    Get full text
    Article
  14. 234
  15. 235
  16. 236
  17. 237
  18. 238
  19. 239

    Prophylactic effect of tenofovir on viral reactivation in immunocompromised pregnant women living with hepatitis B virus by Le Zhang, Shaoying Yang, Yongfu Yu, Suli Wang, Yuetian Yu, Yi Jin, Aimin Zhao, Yimin Mao, Liangjing Lu

    Published 2022-09-01
    “…The prophylactic efficacy and safety of tenofovir disoproxil fumarate (TDF) in hepatitis B surface antigen (HBsAg)–positive patients and the HBVr risk in hepatitis B core antibody (HBcAb)–positive patients during gestation were investigated. …”
    Get full text
    Article
  20. 240